Ischemic heart disease decisions — 2019

The Veteran's claims for service connection for ischemic heart disease and diabetes are being remanded due to the need for additional development regarding his exposure to herbicides in Thailand.

The Board has determined that the appellant's substantive appeal was not timely filed, and therefore remands the case for clarification of the date of the Statement of the Case (SOC) in question.

The Board has remanded the Veteran's claims for service connection for various conditions due to failure to schedule VA examinations. The case is returned to the RO for further development and consideration.

The Board has reopened the claims for service connection for an ear disability and hearing loss, as well as a heart disability. The issues are now remanded for further development.

The Veteran's claim for service connection for ischemic heart disease has been remanded due to the need for a new examination.,Service connection for a blood condition due to exposure to herbicide agents (Agent Orange) is denied.

The claims for service connection are being remanded due to the need for additional information and evidence. The appellant must be notified about her rights to pursue these service connection claims as either a substitute or an accrued benefit claimant.

The Board has reopened the Veteran's claim for service connection for right foot injury due to new and material evidence. The claims for service connection for other conditions are being remanded as they involve issues related to the reopening of the right foot injury claim.

The Veteran's CAD was granted a maximum 100% rating from September 8, 2014 to December 19, 2017 and a 60% rating thereafter. His PTSD received an initial 70% rating effective June 23, 2008.

The Board has granted service connection for coronary artery disease (CAD) on a presumptive basis due to herbicide exposure, including Agent Orange.

The Board has granted service connection for coronary artery disease and Type 2 diabetes mellitus on a presumptive basis due to herbicide exposure, but denied service connection for tinnitus. The Veteran's hypertension is remanded for further development.,Service connection for hypertension secondary to diabetes mellitus is also remanded.

The Board has granted service connection for coronary artery disease (CAD) with an effective date of January 7, 2015.

Service connection is granted for chloracne due to herbicide agent exposure.,Service connection is denied for umbilical hernia and abdominal pain.,Service connection is denied for low back disability, allergic rhinitis, ruptured lung status post staple correction with hemoptysis, heart disability (claimed as heart palpitations), facial skin cancer, colonic polyps, and hypertension.

The Board has remanded the claims for service connection for ischemic heart disease and obstructive sleep apnea due to new evidence. The claim for diabetes mellitus is denied.

The Board has remanded the Veteran's claims for a heart disability, secondary service connection for PTSD and/or diabetes mellitus, type II, and TDIU due to incomplete information in the medical records and the need for further examination.

The Board has remanded the case due to issues regarding an effective date for special monthly compensation and whether a March 8, 2012 rating decision was clearly and unmistakably erroneous.

The Board has remanded the case for further development regarding service connection for the cause of the Veteran's death and a claim of CUE in the effective date of his total disability rating.

The Board has granted service connection for a heart disorder and hypertension, finding that the Veteran's current disabilities are related to his in-service conditions.

The Veteran's appeal is remanded for further development regarding his service-connected coronary artery disease, hypertension secondary to the heart condition, and aortic aneurysm.

The Board denied service connection for chloracne, peripheral neuropathy of the right foot, and ischemic heart disease due to exposure to herbicide agents.

The Veteran's service-connected right lower extremity peripheral neuropathy associated with diabetes mellitus type II is granted at a 20 percent rating, effective from November 19, 2015. The Veteran also receives a TDIU effective from that date.